{"id":"https://openalex.org/W67047131","doi":null,"title":"Formation of indigo by recombinant mammalian cytochrome P450","display_name":"Formation of indigo by recombinant mammalian cytochrome P450","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W67047131","mag":"67047131"},"language":"en","primary_location":{"id":"mag:67047131","doi":null,"is_oa":false,"landing_page_url":"https://espace.library.uq.edu.au/view/UQ:148447","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The FASEB Journal","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Doa Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Doa Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017888348","display_name":"Elizabeth M. J. Gillam","orcid":"https://orcid.org/0000-0003-0378-793X","observed_orcids":["https://orcid.org/0000-0003-0378-793X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth M. J. Gillam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028161464","display_name":"Anna Marie A. Aguinaldo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Marie A. Aguinaldo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087304932","display_name":"Lisa M. Notley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Notley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060156253","display_name":"Ralf G. Mundkowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ralf G. Mundkowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"\u0410. \u0410. \u0412\u043e\u043b\u043a\u043e\u0432","orcid":"https://orcid.org/0000-0002-4305-8726","observed_orcids":["https://orcid.org/0000-0002-4305-8726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0410. \u0410. \u0412\u043e\u043b\u043a\u043e\u0432","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4305-8726","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043841592","display_name":"Frances H. Arnold","orcid":"https://orcid.org/0000-0002-4027-364X","observed_orcids":["https://orcid.org/0000-0002-4027-364X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frances H. Arnold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090756163","display_name":"Pavel Sou\u010dek","orcid":"https://orcid.org/0000-0002-4294-6799","observed_orcids":["https://orcid.org/0000-0002-4294-6799"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pavel Sou\u010dek","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4294-6799","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018549180","display_name":"James J. De Voss","orcid":"https://orcid.org/0000-0002-2659-5140","observed_orcids":["https://orcid.org/0000-0002-2659-5140"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. De Voss","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2659-5140","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058389506","display_name":"Frederick Peter Guengerich","orcid":"https://orcid.org/0000-0002-7458-3048","observed_orcids":["https://orcid.org/0000-0002-7458-3048"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Peter Guengerich","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7458-3048","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.00655977,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"14","issue":"8","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5752000212669373,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5752000212669373,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11747","display_name":"Metal-Catalyzed Oxygenation Mechanisms","score":0.1624000072479248,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10404","display_name":"Enzyme Catalysis and Immobilization","score":0.0786999985575676,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyp2e1","display_name":"CYP2E1","score":0.9670000076293945},{"id":"https://openalex.org/keywords/nadph-cytochrome-p450-reductase","display_name":"NADPH-cytochrome P450 reductase","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tryptophan-degradation","display_name":"tryptophan degradation","score":0.7480000257492065},{"id":"https://openalex.org/keywords/blue-pigments","display_name":"blue pigments","score":0.6050000190734863},{"id":"https://openalex.org/keywords/colorimetric-assay","display_name":"colorimetric assay","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C142316359","wikidata":"https://www.wikidata.org/wiki/Q5967009","display_name":"Indigo","level":2,"score":0.9381974935531616},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.7133886814117432},{"id":"https://openalex.org/C2781109383","wikidata":"https://www.wikidata.org/wiki/Q898497","display_name":"Hydroxylation","level":3,"score":0.6745177507400513},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.6666654944419861},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.6467528343200684},{"id":"https://openalex.org/C64584667","wikidata":"https://www.wikidata.org/wiki/Q161179","display_name":"Pigment","level":2,"score":0.6083052754402161},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5739946365356445},{"id":"https://openalex.org/C192527728","wikidata":"https://www.wikidata.org/wiki/Q1465700","display_name":"Indole test","level":2,"score":0.5533848404884338},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4955822229385376},{"id":"https://openalex.org/C197957613","wikidata":"https://www.wikidata.org/wiki/Q407280","display_name":"Cofactor","level":3,"score":0.4322688579559326},{"id":"https://openalex.org/C171305022","wikidata":"https://www.wikidata.org/wiki/Q5201343","display_name":"Cytochrome P450 reductase","level":5,"score":0.4105914831161499},{"id":"https://openalex.org/C29311851","wikidata":"https://www.wikidata.org/wiki/Q408223","display_name":"Cytochrome c","level":3,"score":0.24744874238967896},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.11522045731544495},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.10536789894104004},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10153660178184509},{"id":"https://openalex.org/C14471203","wikidata":"https://www.wikidata.org/wiki/Q412832","display_name":"Coenzyme Q \u2013 cytochrome c reductase","level":4,"score":0.09821778535842896},{"id":"https://openalex.org/C153349607","wikidata":"https://www.wikidata.org/wiki/Q36649","display_name":"Visual arts","level":1,"score":0.0},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:67047131","doi":null,"is_oa":false,"landing_page_url":"https://espace.library.uq.edu.au/view/UQ:148447","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The FASEB Journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1986333080","https://openalex.org/W6959835290","https://openalex.org/W4402030506","https://openalex.org/W973041472","https://openalex.org/W1999318700","https://openalex.org/W4318054763","https://openalex.org/W2112863694","https://openalex.org/W2016100028","https://openalex.org/W7095855984","https://openalex.org/W2119197747"],"abstract_inverted_index":{"The":[0,53],"development":[1,165],"of":[2,7,34,46,79,93,105,139,154,166],"bicistronic":[3],"systems":[4],"for":[5,77],"coexpression":[6],"recombinant":[8,35,122],"human":[9,126],"cytochrome":[10],"P450":[11,19,24,36,113,123,156],"enzymes":[12,157],"(P450s)":[13],"with":[14,63,132],"their":[15],"redox":[16],"partner,":[17],"NADPH-cytochrome":[18],"reductase":[20],"(NPR),":[21],"has":[22],"enabled":[23],"activity":[25],"to":[26,61,87,116,136],"be":[27],"reconstituted":[28],"within":[29],"bacterial":[30,51],"cells.":[31],"During":[32],"expression":[33],"2E1":[37,124],"and":[38,59,70,125,134,146],"some":[39],"other":[40],"forms,":[41],"we":[42,96],"observed":[43],"the":[44,80,90,112,164],"formation":[45,138],"a":[47,102,140,144],"blue":[48,141],"pigment":[49,54,81,142],"in":[50,107,130,143,158,163],"cultures.":[52],"was":[55,109],"extracted":[56],"from":[57],"cultures":[58],"shown":[60,135],"comigrate":[62],"standard":[64],"indigo":[65,117,160],"on":[66,171],"TLC,":[67],"UV-visible":[68],"spectroscopy":[69],"mass":[71],"spectrometric":[72],"analysis":[73],"provided":[74],"further":[75],"support":[76],"identification":[78],"as":[82,101],"indigo.":[83],"Indigo":[84],"is":[85],"known":[86],"form":[88],"following":[89],"spontaneous":[91],"oxidation":[92],"8-hydroxyindole.":[94],"Accordingly,":[95],"speculated":[97],"that":[98],"indole,":[99],"formed":[100],"breakdown":[103],"product":[104],"tryptophan":[106],"bacteria,":[108],"hydroxylated":[110],"by":[111],"system,":[114],"leading":[115],"formation.":[118],"Bacterial":[119],"membranes":[120],"containing":[121],"NPR":[127],"were":[128],"incubated":[129],"vitro":[131],"indole":[133,172],"catalyze":[137],"time-":[145],"cofactor-dependent":[147],"manner.":[148],"These":[149],"studies":[150],"suggest":[151],"potential":[152],"applications":[153],"mammalian":[155],"industrial":[159],"production":[161],"or":[162],"novel":[167],"colorimetric":[168],"assays":[169],"based":[170],"hydroxylation.":[173]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}